Nvidia to take minority stake in French health platform Doctolib to speed AI drug development
Polymarket · x · 2026-10-14
Per Polymarket, Nvidia is acquiring a minority stake in French healthcare platform Doctolib, aiming to accelerate AI drug development.
More from Venture
- CoreWeave unsecured notes yield 15.1% as spread hits 1,000 bps on H100 collateral fears — ivan_bezdomny · 2026-10-14
- AI search startup Exa hits $100M annualized revenue, growing ~10x a year for 3 years — TheIshanGoswami · 2026-10-14
- Latent Space cloned a $43K/yr SaaS with AI agents: 72 teams, $10K winner, lessons learned — Latent Space · 2026-10-14
- Nvidia takes stake in Doctolib as Jensen Huang pushes AI revolution in Europe — mitchdeg · 2026-10-14
- The Global AI Bust: What Will Survive When the Boom Ends — ForeignAffairsMag · 2026-10-14
- Lenny's Newsletter: what actually counts as a moat in the AI era — HamelHusain · 2026-10-14